Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Leukemia|June 29, 2007
Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia veraA Pardanani, T L Lasho, C Finke, et al.Leukemia|April 23, 2010
IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasmsA Pardanani, T L Lasho, C M Finke, et al.Leukemia|June 22, 2011
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patientsA Pardanani, P Guglielmelli, T L Lasho, et al.Leukemia|September 14, 2011
IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromesA Pardanani, C Finke, T L Lasho, et al.Leukemia|October 23, 2009
The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patientsA Pardanani, T L Lasho, C M Finke, et al.Blood Cancer Journal|January 16, 2016
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemiaM M Patnaik, T L Lasho, P Vijayvargiya, et al.Leukemia|September 14, 2011
IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617FA Tefferi, T Jimma, N H Sulai, et al.Leukemia|January 25, 2008
Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survivalA Tefferi, T L Lasho, J Huang, et al.Blood Cancer Journal|January 24, 2015
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemiaT L Lasho, C M Finke, D Zblewski, et al.Leukemia|April 7, 2006
JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplainedD P Steensma, R F McClure, J E Karp, et al.Pageof 3